AltruBio
Developer of first-in-class immune-modulators to target diseases of the immune system. The company has clinically validated a first-in-class immune checkpoint regulator mechanism to selectively target...
Valuation
$0
Share Price
N/A
Total Raised
$336.6M
Last Round
N/A